Skip to main content
Livermore
Livermore
ZHEN

Superstring Capital Management LP

SEC CIK
0001931118
Latest filing
Aug 14, 2026

Holdings in Q3 2024

Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.

Institution overview
Positions
27
−12 vs. Q2 2024
Portfolio value
$111.8M
+$32.5M (+41.0%) vs. Q2 2024
Filed
Nov 14, 2024
SEC
Holdings of Superstring Capital Management LP in Q3 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
ZLABZai Lab LtdADR626,932$15.1M13.5%+411,754+191.4%AddedHistory
CYTKCytokinetics IncCOM NEW215,798$11.4M10.2%+28,165+15.0%AddedHistory
TERNTerns Pharmaceuticals, Inc.COM1,348,546$11.2M10.1%+392,004+41.0%AddedHistory
GPCRStructure Therapeutics Inc.SPONSORED ADS227,047$9.97M8.9%+227,047NewHistory
ORICOric Pharmaceuticals, Inc.COM949,522$9.73M8.7%+949,522NewHistory
TILInstil Bio, Inc.COM NEW107,545$7.24M6.5%+107,545NewHistory
NVCRNovoCure LtdORD SHS392,711$6.14M5.5%+325,819+487.1%AddedHistory
BBIOBridgeBio Pharma, Inc.COM226,684$5.77M5.2%+6,847+3.1%AddedHistory
FATEFate Therapeutics IncCOM1,466,934$5.13M4.6%+969,574+194.9%AddedHistory
CAPRCapricor Therapeutics, Inc.COM NEW337,347$5.13M4.6%+337,347NewHistory
TNGXTango Therapeutics, Inc.COM599,048$4.61M4.1%+483,477+418.3%AddedHistory
ETNB89bio, Inc.COM595,203$4.40M3.9%−85,200−12.5%ReducedHistory
NKTXNkarta, Inc.COM740,294$3.35M3.0%−135,705−15.5%ReducedHistory
LEGNLegend Biotech CorpSPONSORED ADS60,515$2.95M2.6%−94,150−60.9%ReducedHistory
ZBIOZenas BioPharma, Inc.COM111,605$1.89M1.7%+111,605NewHistory
ALLOAllogene Therapeutics, Inc.COM478,115$1.34M1.2%−211,797−30.7%ReducedHistory
SYRESpyre Therapeutics, Inc.COM NEW37,287$1.10M1.0%−8,284−18.2%ReducedHistory
SVRASavara IncCOM200,000$848.0K0.8%00.0%UnchangedHistory
BMEABiomea Fusion, Inc.COM83,554$843.9K0.8%−83,556−50.0%ReducedHistory
TRMLTourmaline Bio, Inc.COM29,104$748.3K0.7%−66,125−69.4%ReducedHistory
ZURAZura Bio LtdCLASS A ORD SHS156,626$635.9K0.6%00.0%UnchangedHistory
CABACabaletta Bio, Inc.COM131,795$622.1K0.6%−8,100−5.8%ReducedHistory
CRBPCorbus Pharmaceuticals Holdings, Inc.COM NEW25,401$524.0K0.5%−31,067−55.0%ReducedHistory
IMVTImmunovant, Inc.COM12,447$354.9K0.3%+12,447NewHistory
CGEMCullinan Therapeutics, Inc.COM20,840$348.9K0.3%+20,840NewHistory
Ys Biopharma Co LtdG9845F109ORDINARY SHARES307,920$212.2K0.2%00.0%Unchanged–
CLYMClimb Bio, Inc.COM33,824$172.2K0.2%+33,824NewHistory

Options (1)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Superstring Capital Management LP in Q3 2024
SecurityClassPutsCalls
ZLABZai Lab LtdADR–$2.41M

Sold out since Q2 2024 (20)

Positions held at the end of Q2 2024 that are gone from this filing.

Positions of Superstring Capital Management LP sold out since Q2 2024
SecurityClassShares in Q2 2024Value in Q2 2024% of portfolio in Q2 2024History
KROSKeros Therapeutics, Inc.COM74,288$3.39M4.3%History
ACLXArcellx, Inc.COMMON STOCK59,133$3.26M4.1%History
ARWRArrowhead Pharmaceuticals, Inc.COM111,133$2.89M3.6%History
ONCBeOne Medicines Ltd.ADR12,508$1.78M2.2%History
PYXSPyxis Oncology, Inc.COMMON STOCK484,443$1.60M2.0%History
APGEApogee Therapeutics, Inc.COM36,928$1.45M1.8%History
CTMXCytomX Therapeutics, Inc.COM1,151,518$1.40M1.8%History
NAMSNewAmsterdam Pharma Co N.V.ORDINARY SHARES64,213$1.23M1.6%History
ALLKAllakos Inc.COM940,578$940.6K1.2%History
CATXPerspective Therapeutics, Inc.COM NEW87,638$873.8K1.1%History
KURAKura Oncology, Inc.COM36,242$746.2K0.9%History
ATYRaTYR PHARMA INCCOM NEW313,028$488.3K0.6%History
PEPGPepGen Inc.COM29,249$466.8K0.6%History
KPTIKaryopharm Therapeutics Inc.COM534,485$463.7K0.6%History
EYPTEyePoint, Inc.COM NEW37,838$329.2K0.4%History
MRNSMarinus Pharmaceuticals, Inc.COM NEW261,861$306.4K0.4%History
MRSNMersana Therapeutics, Inc.COM110,073$221.2K0.3%History
CMPSCOMPASS Pathways plcSPONSORED ADS32,497$196.3K0.2%History
SYRSSyros Pharmaceuticals, Inc.COM NEW37,789$195.0K0.2%History
SPRBSpruce Biosciences, Inc.COM77,992$40.4K0.1%History